Myocarditis following rAd26 and rAd5 vector-based COVID-19 vaccine: case report

ESC Heart Fail. 2022 Apr;9(2):1483-1486. doi: 10.1002/ehf2.13821. Epub 2022 Feb 1.

Abstract

SARS-CoV-2 vaccines provide a safe solution with a major impact on reducing the spread of the virus and mild side effects. Research has shown rare cases of myocarditis after mRNA vaccines. This study presents a 29-year-old male with chest pain after 48 h of receiving rAd26 and rAd5 vector-based COVID-19 vaccine (Sputnik V vaccine). The electrocardiogram revealed ST-segment elevation. Also, the laboratory screening was remarkable for elevated cardiac Troponin-I level, and leukocytosis; and echocardiography depicted severe left ventricular systolic dysfunction. Overall, endomyocardial biopsy proved lymphocytic myocarditis such that the patient was successfully treated with immunosuppressive and guideline-directed medical treatment.

Keywords: Cardiovascular; Complication; Gam-COVID-Vac; SARS-CoV-2; Sputnik V vaccine.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • COVID-19 Vaccines / adverse effects
  • COVID-19*
  • Heart
  • Humans
  • Male
  • Myocarditis* / diagnosis
  • Myocarditis* / etiology
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines